Percutaneous coronary intervention or prehospital thrombolysis? What is the preferred treatment in S-T elevation myocardial infarction?

Internal Medicine Journal

Volumn 42, Issue SUPPL.5, 2012, Pages 44-46

  Hiscock, M ^a  

^a EPWORTH HOSPITAL   (Australia)

Author keywords

Percutaneous coronary intervention; S T elevation; Thrombolysis

Indexed keywords

ABCIXIMAB; FIBRINOLYTIC AGENT;

ANGIOCARDIOGRAPHY; ARTICLE; BRAIN HEMORRHAGE; ELECTROCARDIOGRAPHY; EMERGENCY CARE; FIBRINOLYTIC THERAPY; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

CLINICAL TRIALS AS TOPIC; EMERGENCY MEDICAL SERVICES; HUMANS; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 84867214817     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2012.02922.x     Document Type: Article

References (9)

1. Assessment of the safety and efficacy of anew treatment strategy with percutaneous coronary intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006; 367: 569-578.
2. Kastrati A, Mehilli J, Schotterbeck K, Dotzer F, Dirschinger J, Schmitt C etal. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referral for percutaneous coronary intervention. JAMA 2004; 291: 947-954.
3. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L etal. FINESSE investigators. FAcilitated PCI in patients with ST- elevation myocardial infarction. N Engl J Med 2008; 358: 2205-2217.
4. Widimsky P, Groch L, Zelizko M, Aschermann M, Bednár F, Suryapranata H. Multicentre randomised trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000; 21: 823-831.
5. Grines CL, Westerhausen DR Jr, Grines LL, Hanlon JT, Logemann TL, Niemela M etal. A randomised trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the air primary angioplasty in myocardial infarction study. J Am Coll Cardiol 2002; 39: 1713-1719.
6. Anderson HR, Nielsen TT, Vesterlund T, Grande P, Abildgaard U, Thayssen P etal. A comparison of coronary angioplasty with fibrinolytic therapy versus acute coronary angioplasty in acute myocardial infarction: rationale and design of the DANAMI-2 trial. Am Heart J 2003; 146: 234-241.
7. Dalby M, Bouzamando A, Lechat P, Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction. Circulation 2003; 108: 809-814.
8. Acute Coronary Syndrome Guidelines Working Group. Guidelines for the management of acute coronary syndromes 2006. Med J Aust 2006; 184 (Suppl): S1-S32.
9. Bohmer E, Hoffman P, Abdelnoor M, Arnesen H, Halvorsen S. Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances: results of the NORDISTEMI (NORwegian study on District treatment of ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2010; 55: 102-110.